LP

Louis Picker

OU Oregon Health & Science University: 21 patents #4 of 725Top 1%
TS Triad National Security: 3 patents #69 of 533Top 15%
VB Vir Biotechnology: 3 patents #2 of 21Top 10%
Becton, Dickinson And: 3 patents #937 of 2,926Top 35%
II International Aids Vaccine Initiative: 2 patents #45 of 110Top 45%
SU Stanford University: 1 patents #58 of 261Top 25%
University Of Texas System: 1 patents #2,951 of 6,559Top 45%
📍 Portland, OR: #707 of 9,213 inventorsTop 8%
🗺 Oregon: #1,562 of 28,073 inventorsTop 6%
Overall (All Time): #152,567 of 4,157,543Top 4%
26
Patents All Time

Issued Patents All Time

Showing 1–25 of 26 patents

Patent #TitleCo-InventorsDate
11834669 Recombinant cytomegalovirus vectors as vaccines for tuberculosis Thomas G. Evans, Ravi P. Anantha, Aurelio M. Bonavia, Dominick Laddy, Scott Hansen +1 more 2023-12-05
11692012 Human cytomegalovirus comprising exogenous antigens Klaus Frueh, Scott Hansen, Jay Nelson, Patrizia Caposio 2023-07-04
11628215 HIV vaccines comprising one or more population episensus antigens Eric Bruening, Klaus Frueh, Bette T. Korber, James Theiler, Emily Marshall 2023-04-18
11554168 HIV vaccines comprising one or more population episensus antigens Eric Bruening, Klaus Frueh, Bette T. Korber, James Theiler, Emily Marshall 2023-01-17
11305015 Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules Scott Hansen, Klaus Frueh, Daniel Malouli, Jay Nelson, Jonah Sacha +1 more 2022-04-19
11266732 Recombinant HCMV and RHCMV vectors and uses thereof Jay Nelson, Klaus Frueh, Michael A. Jarvis, Scott Hansen 2022-03-08
11091775 Recombinant cytomegalovirus vectors as vaccines for tuberculosis Thomas G. Evans, Ravi P. Anantha, Aurelio M. Bonavia, Dominick Laddy, Scott Hansen +1 more 2021-08-17
11091779 Methods and compositions useful in generating non canonical CD8+ T cell responses Klaus Frueh, Scott Hansen, Jonah Sacha, Daniel Malouli 2021-08-17
10995121 Human cytomegalovirus comprising exogenous antigens Klaus Frueh, Scott Hansen, Jay Nelson, Patrizia Caposio 2021-05-04
10894078 HIV vaccines comprising one or more population episensus antigens Eric Bruening, Klaus Frueh, Bette T. Korber, James Theiler, Emily Marshall 2021-01-19
10760097 CMV glycoproteins and recombinant vectors Klaus Früh, Scott Hansen 2020-09-01
10688164 CMV vectors comprising microRNA recognition elements Jay Nelson, Scott Hansen, Meaghan Hancock, Klaus Frueh 2020-06-23
10532099 Cytomegalovirus vectors eliciting T cells restricted by major histocompatibility complex E molecules Scott Hansen, Klaus Frueh, Daniel Malouli, Jay Nelson, Jonah Sacha +1 more 2020-01-14
10428118 Human cytomegalovirus comprising exogenous antigens Klaus Frueh, Scott Hansen, Jay Nelson, Patrizia Caposio 2019-10-01
10316334 Cytomegalovirus vectors enabling control of T cell targeting Scott Hansen, Klaus Frueh, Daniel Malouli 2019-06-11
10101329 CMV glycoproteins and recombinant vectors Klaus Frueh, Scott Hansen, Colin Powers 2018-10-16
9982241 Recombinant HCMV and RHCMV vectors and uses thereof Jay Nelson, Klaus Frueh, Michael A. Jarvis, Scott Hansen 2018-05-29
9862972 CMV glycoproteins and recombinant vectors Klaus Früh, Scott Hansen 2018-01-09
9783823 Cytomegalovirus vectors enabling control of T cell targeting Scott Hansen, Klaus Frueh, Daniel Malouli 2017-10-10
9541553 CMV glycoproteins and recombinant vectors Klaus Frueh, Scott Hansen, Collin Powers 2017-01-10
9249427 Recombinant HCMV and RHCMV vectors and uses thereof Jay Nelson, Klaus Frueh, Michael A. Jarvis, Scott Hansen 2016-02-02
7514232 Method for detecting T cell response to specific antigens in whole blood Vernon C. Maino, Maria Suni 2009-04-07
5622853 T lymphocyte precursor Leon W. M. M. Terstappen 1997-04-22
5612185 Method for identifying tumor cells in cell cycle arrest Jonathan W. Uhr, Ellen S. Vitetta, Richard H. Scheuermann 1997-03-18
5583033 T lymphocyte precursor Leon W. M. M. Terstappen 1996-12-10